Literature DB >> 18805686

Why don't out-of-treatment individuals enter methadone treatment programmes?

James A Peterson1, Robert P Schwartz, Shannon Gwin Mitchell, Heather Schacht Reisinger, Sharon M Kelly, Kevin E O'Grady, Barry S Brown, Michael H Agar.   

Abstract

BACKGROUND: Despite the proven effectiveness of methadone treatment, the majority of heroin-dependent individuals are out-of-treatment.
METHODS: Twenty-six opioid-dependent adults who met the criteria for methadone maintenance who were neither seeking methadone treatment at the time of study enrollment, nor had participated in such treatment during the past 12 months, were recruited from the streets of Baltimore, Maryland through targeted sampling. Ethnographic interviews were conducted to ascertain participants' attitudes toward methadone treatment and their reasons for not seeking treatment.
RESULTS: Barriers to treatment entry included: waiting lists, lack of money or health insurance, and requirements to possess a photo identification card. For some participants, beliefs about methadone such as real or rumored side effects, fear of withdrawal from methadone during an incarceration, or disinterest in adhering to the structure of treatment programmes kept them from applying. In addition, other participants were not willing to commit to indefinite "maintenance" but would have accepted shorter time-limited methadone treatment.
CONCLUSION: Barriers to treatment entry could be overcome by an infusion of public financial support to expand treatment access, which would reduce or eliminate waiting lists, waive treatment-related fees, and/or provide health insurance coverage for treatment. Treatment programmes could overcome some of the barriers by waiving their photo I.D. requirements, permitting time-limited treatment with the option to extend such treatment upon request, and working with corrections agencies to ensure continued methadone treatment upon incarceration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805686      PMCID: PMC2790538          DOI: 10.1016/j.drugpo.2008.07.004

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  43 in total

1.  Beliefs about methadone in an inner-city methadone clinic.

Authors:  Sharon Stancliff; Julie Elana Myers; Stuart Steiner; Ernest Drucker
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment.

Authors:  Donald A Calsyn; Frank J DeMarco; Andrew J Saxon; Kevin L Sloan; Karen E Gibbon
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

3.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

4.  Review of E. Preble and J. J. Casey, "Taking care of business--the heroin user's life on the street, " International Journal of the Addictions, 4: 1-24 (1969).

Authors:  R Dembo
Journal:  Subst Use Misuse       Date:  1997-01       Impact factor: 2.164

5.  The functioning of individuals on a drug abuse treatment waiting list.

Authors:  B S Brown; J E Hickey; A S Chung; R D Craig; J H Jaffe
Journal:  Am J Drug Alcohol Abuse       Date:  1989       Impact factor: 3.829

Review 6.  Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.

Authors:  D C Lewis
Journal:  J Addict Dis       Date:  1999

7.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

8.  In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; James A Peterson; Heather S Reisinger; Shannon G Mitchell; Monique E Wilson; Michael H Agar; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

9.  A coupon program--drug treatment and AIDS education.

Authors:  J F Jackson; L G Rotkiewicz; M A Quinones; M R Passannante
Journal:  Int J Addict       Date:  1989-11

Review 10.  Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs.

Authors:  D C Des Jarlais; D Paone; S R Friedman; N Peyser; R G Newman
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

View more
  70 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

Review 3.  Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Authors:  Paolo Mannelli; Kathleen S Peindl; Tong Lee; Kamal S Bhatia; Li-Tzy Wu
Journal:  Curr Drug Abuse Rev       Date:  2012-03

4.  Gaps in the Substance Use Disorder Treatment Referral Process: Provider Perceptions.

Authors:  Claire E Blevins; Nishi Rawat; Michael D Stein
Journal:  J Addict Med       Date:  2018 Jul/Aug       Impact factor: 3.702

5.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

6.  The impact of financial discharge from methadone maintenance therapy on incarceration.

Authors:  Nickolas D Zaller; Jeannia J Fu; Alexander R Bazazi; Josiah D Rich
Journal:  J Opioid Manag       Date:  2010 Sep-Oct

7.  Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.

Authors:  Zoe M Weinstein; Gabriela Gryczynski; Debbie M Cheng; Emily Quinn; David Hui; Hyunjoong W Kim; Colleen Labelle; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2018-06-19       Impact factor: 4.492

8.  Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside?

Authors:  Meldon Kahan; Anita Srivastava; Brian Conway
Journal:  Can J Public Health       Date:  2011 Mar-Apr

9.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun

10.  Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities.

Authors:  Nickolas D Zaller; Alexander R Bazazi; Lavinia Velazquez; Josiah D Rich
Journal:  Int J Environ Res Public Health       Date:  2009-02-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.